-
1
المؤلفون: Hok Bing Thio, Errol P. Prens, C. I. Busard, M. Wakkee, Ph.I. Spuls, M. de Groot, W. J. A. de Kort, Alexander Nast, L.L.A. Lecluse, P.P.M. van Lümig, G. E. van der Kraaij, Marieke M B Seyger, Stefanie Rosumeck, R.J.B. Driessen, J.M.P.A. van den Reek, S.P. Menting, S. A. Karsch, A. Jacobs, W. R. Veldkamp, Deepak M.W. Balak, Y. Chung, E.M.G.J. de Jong, O.D. van Cranenburgh, Aniek Lamberts, P. M. J. H. Kemperman
المساهمون: Dermatology, APH - Methodology, AII - Inflammatory diseases, APH - Quality of Care, Graduate School, ACS - Diabetes & metabolism, Medical Psychology, APH - Personalized Medicine
المصدر: The British Journal of Dermatology
van der Kraaij, G E, Balak, D M W, Busard, C I, van Cranenburgh, O D, Chung, Y, Driessen, R J B, de Groot, M, de Jong, E M G J, Kemperman, P M J H, de Kort, W J A, Karsch, S A, Lamberts, A, Lecluse, L L A, van Lümig, P P M, Menting, S P, Prens, E P, van den Reek, J M P A, Seyger, M M B, Thio, H B, Veldkamp, W R, Wakkee, M, Nast, A, Jacobs, A, Rosumeck, S & Spuls (Chair), P I 2019, ' Highlights of the updated Dutch evidence-and consensus-based guideline on psoriasis 2017 ', British Journal of Dermatology, vol. 180, no. 1, pp. 31-42 . https://doi.org/10.1111/bjd.17198
British Journal of Dermatology, 180(1), 31-42. Wiley-Blackwell
BRITISH JOURNAL OF DERMATOLOGY, 180(1), 31-42. Wiley
British Journal of Dermatology, 180, 1, pp. 31-42
British Journal of Dermatology, 180, 31-42
British journal of dermatology, 180(1), 31-42. Wiley-Blackwell
British Journal of Dermatology, 180(1), 31-42. Wiley-Blackwell Publishing Ltdمصطلحات موضوعية: SYSTEMIC AGENTS, medicine.medical_specialty, Consensus, TREATMENT SATISFACTION, MEDLINE, Evidence‐Based Dermatology, IMPROVEMENT, Dermatology, Guideline, Treatment satisfaction, All institutes and research themes of the Radboud University Medical Center, Quality of life (healthcare), Disease severity, QUALITY-OF-LIFE, Psoriasis, medicine, Humans, Intensive care medicine, Societies, Medical, Netherlands, Evidence-Based Medicine, business.industry, Other Research Radboud Institute for Health Sciences [Radboudumc 0], PSYCHOLOGICAL BURDEN, medicine.disease, METHOTREXATE, Fumaric Acid Esters, Practice Guidelines as Topic, DISEASE SEVERITY, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], MODERATE, FUMARIC-ACID ESTERS, business, SKIN DISEASES
وصف الملف: application/pdf
-
2
المؤلفون: Jo Lambert, Juul M. P. A. van den Reek, Barbara A. Hutten, Antonio Costanzo, Phyllis I. Spuls, Jeffrey Zweegers, Sven Lanssens, Lieve Meuleman, Eline De Keyser, C. I. Busard
المساهمون: APH - Quality of Care, AII - Inflammatory diseases, ACS - Diabetes & metabolism, APH - Methodology, Graduate School, Dermatology, Epidemiology and Data Science, APH - Health Behaviors & Chronic Diseases, APH - Aging & Later Life
المصدر: Therapeutic Drug Monitoring
Therapeutic drug monitoring, 41(5), 634-639. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 41, 634-639
Therapeutic Drug Monitoring, 41, 5, pp. 634-639
THERAPEUTIC DRUG MONITORINGمصطلحات موضوعية: Male, PHARMACOKINETICS, Placebo-controlled study, immunogenicity, PLACEBO-CONTROLLED TRIAL, Severity of Illness Index, 030226 pharmacology & pharmacy, CHRONIC INFLAMMATORY DISEASES, 0302 clinical medicine, Medicine and Health Sciences, Pharmacology (medical), Prospective Studies, Prospective cohort study, Netherlands, drug monitoring, PSORIASIS, psoriasis, ANTIDRUG ANTIBODIES, Middle Aged, Treatment Outcome, Cohort, Female, Original Article, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], medicine.drug, medicine.medical_specialty, HLA-C Antigens, ustekinumab, 03 medical and health sciences, Psoriasis Area and Severity Index, Internal medicine, Psoriasis, Ustekinumab, Severity of illness, Adalimumab, medicine, Humans, Pharmacology, PHARMACOGENETICS, business.industry, EFFICACY, medicine.disease, TO-SEVERE, RHEUMATOID-ARTHRITIS, Methotrexate, Antibody Formation, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], business, Biomarkers, ADALIMUMAB
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb2e7b56a9dae08c0eb230fa2bb0b54
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/208399 -
3
المؤلفون: Arnon D. Cohen, Simone Cazzaniga, Philipp Wolf, Ilan Feldhamer, E Adenubiova, Barbara A. Hutten, Luigi Naldi, Franz Quehenberger, C. I. Busard, Spyridon Gkalpakiotis, Antonio Addis, R. Lichem, Robert S. Stern, Ph.I. Spuls, Martina Kojanová
المساهمون: APH - Quality of Care, APH - Methodology, APH - Health Behaviors & Chronic Diseases, APH - Aging & Later Life, Epidemiology and Data Science, ACS - Amsterdam Cardiovascular Sciences, AII - Inflammatory diseases, Dermatology, AII - Amsterdam institute for Infection and Immunity, ACS - Diabetes & metabolism
المصدر: Journal of the European Academy of Dermatology and Venereology, 32(2), 245-253. Wiley-Blackwell
مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Kaplan-Meier Estimate, Dermatology, Severity of Illness Index, Etanercept, Acitretin, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Fumarates, Psoriasis, Ustekinumab, Adalimumab, Humans, Medicine, Registries, Israel, 610 Medicine & health, PUVA Therapy, Czech Republic, Netherlands, 030203 arthritis & rheumatology, Biological Products, business.industry, Middle Aged, medicine.disease, Combined Modality Therapy, Infliximab, Methotrexate, Infectious Diseases, Italy, Austria, PUVA therapy, Cyclosporine, Drug Therapy, Combination, Female, Dermatologic Agents, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fabfe14f23d0b58817ccf14db157b943
https://pure.amc.nl/en/publications/biologics-combined-with-conventional-systemic-agents-or-phototherapy-for-the-treatment-of-psoriasis-reallife-data-from-psonet-registries(12a0048e-e0f7-4d10-8043-2017b5d68c89).html -
4
المؤلفون: Marcel C. Pasch, J. Y. C. Nolte, C. I. Busard, Ph.I. Spuls
المساهمون: APH - Quality of Care, APH - Methodology, AII - Inflammatory diseases, Dermatology, AII - Amsterdam institute for Infection and Immunity, ACS - Diabetes & metabolism
المصدر: British Journal of Dermatology, 178, 3, pp. 640-649
British Journal of Dermatology, 178, 640-649
British journal of dermatology, 178(3), 640-649. Wiley-Blackwellمصطلحات موضوعية: Research design, medicine.medical_specialty, Dermatology, Severity of Illness Index, law.invention, 030207 dermatology & venereal diseases, 03 medical and health sciences, Nail Diseases, 0302 clinical medicine, Randomized controlled trial, Quality of life, law, Psoriasis, Severity of illness, Activities of Daily Living, medicine, Humans, Patient Reported Outcome Measures, Randomized Controlled Trials as Topic, 030203 arthritis & rheumatology, integumentary system, business.industry, Other Research Radboud Institute for Health Sciences [Radboudumc 0], medicine.disease, Surgery, Clinical trial, medicine.anatomical_structure, Treatment Outcome, Research Design, Meta-analysis, Nail (anatomy), Physical therapy, Quality of Life, business, Delivery of Health Care
-
5
المؤلفون: J.M.P.A. van den Reek, S.P. Menting, Errol P. Prens, C. I. Busard, Jine S. van Bezooijen, Martijn B. A. van Doorn, Phyllis I. Spuls, Elke de Jong, Barbara A. Hutten
المصدر: Trials
مصطلحات موضوعية: Pragmatic, medicine.medical_specialty, Time Factors, Medicine (miscellaneous), Severity of Illness Index, law.invention, Study Protocol, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Clinical Protocols, law, Psoriasis, Internal medicine, medicine, Adalimumab, Humans, Pharmacology (medical), Single-Blind Method, 030212 general & internal medicine, Combination therapy, Multicenter, Netherlands, Skin, Biological Products, business.industry, Tumor Necrosis Factor-alpha, Remission Induction, medicine.disease, 3. Good health, Surgery, Methotrexate, Treatment Outcome, Research Design, Concomitant, Quality of Life, Drug Therapy, Combination, Erratum, business, 030217 neurology & neurosurgery, Immunosuppressive Agents, medicine.drug
-
6
المؤلفون: M.B.A. van Doorn, E. M. de Jong, J.M.P.A. van den Reek, S.P. Menting, Errol P. Prens, Barbara A. Hutten, J. S. van Bezooijen, Ph.I. Spuls, C. I. Busard
المساهمون: Dermatology, APH - Quality of Care, AII - Inflammatory diseases, APH - Methodology, Other departments, APH - Personalized Medicine, APH - Health Behaviors & Chronic Diseases, APH - Aging & Later Life, Epidemiology and Data Science, ACS - Diabetes & metabolism
المصدر: Trials, 18
Trials, 18:52. BioMed Central Ltd.
Trials, 18(1). BioMed Centralمصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Combination therapy, Population, Medicine (miscellaneous), law.invention, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Psoriasis Area and Severity Index, law, Psoriasis, Internal medicine, medicine, Adalimumab, Pharmacology (medical), skin and connective tissue diseases, education, 030203 arthritis & rheumatology, education.field_of_study, business.industry, medicine.disease, 3. Good health, Tolerability, Concomitant, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Physical therapy, business, medicine.drug
وصف الملف: application/pdf
-
7
المؤلفون: C. I. Busard, Miranda W. Langendam, Jeffrey Zweegers, Phyllis I. Spuls, Jacqueline Limpens
المصدر: JAMA dermatology. 150(11)
مصطلحات موضوعية: medicine.medical_specialty, Combination therapy, MEDLINE, Drug Resistance, Dermatology, Cochrane Library, Receptors, Tumor Necrosis Factor, Etanercept, law.invention, Randomized controlled trial, law, Psoriasis Area and Severity Index, medicine, Combined Modality Therapy, Humans, Psoriasis, Intensive care medicine, Adverse effect, Dose-Response Relationship, Drug, business.industry, Surgery, Methotrexate, Immunoglobulin G, Drug Therapy, Combination, Dermatologic Agents, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f28d87c4f495a76e4dcfda55a18bb4f4
https://pubmed.ncbi.nlm.nih.gov/25188393